Cargando…
Muscle mass versus body mass index as predictor of adverse outcome
Autores principales: | Groothof, Dion, Post, Adrian, Polinder‐Bos, Harmke A., Hazenberg, Bouke P.C., Gans, Reinold O.B., Bakker, Stephan J.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061409/ https://www.ncbi.nlm.nih.gov/pubmed/33583115 http://dx.doi.org/10.1002/jcsm.12686 |
Ejemplares similares
-
Muscle mass and estimates of renal function: a longitudinal cohort study
por: Groothof, Dion, et al.
Publicado: (2022) -
Sodium–Glucose Cotransporter 2 Inhibitors and Kidney Outcomes: True Renoprotection, Loss of Muscle Mass or Both?
por: Post, Adrian, et al.
Publicado: (2020) -
Tolvaptan, Kidney Function Decline, and Potential Confounding by Muscle Wasting
por: Groothof, Dion, et al.
Publicado: (2023) -
Relationship between body mass index, cardiovascular biomarkers and incident heart failure
por: Suthahar, Navin, et al.
Publicado: (2021) -
Lower body mass index and mortality in older adults starting dialysis
por: Polinder-Bos, Harmke A., et al.
Publicado: (2018)